Cyclodextrin-Modified Polyethylenimine Polymers for Gene Delivery
Citations Over TimeTop 10% of 2004 papers
Abstract
Linear and branched poly(ethylenimines), lPEI and bPEI, respectively, grafted with beta-cyclodextrin are prepared to give CD-lPEI and CD-bPEI, respectively, and are investigated as in vitro and in vivo nonviral gene delivery agents. The in vitro toxicity and transfection efficiency are sensitive to the level of cyclodextrin grafting. The cyclodextrin-containing polycations, when combined with adamantane-poly(ethylene glycol) (AD-PEG) conjugates, form particles that are stable at physiological salt concentrations. PEGylated CD-lPEI-based particles give in vitro gene expression equal to or greater than lPEI as measured by the percentage of EGFP expressing cells. Tail vein injections into mice of 120 microg of plasmid DNA formulated with CD-lPEI and AD-PEG do not reveal observable toxicities, and both nucleic acid accumulation and expression are observed in liver.
Related Papers
- → A Degradable Polyethylenimine Derivative with Low Toxicity for Highly Efficient Gene Delivery(2003)384 cited
- → Charge shielding effects on gene delivery of polyethylenimine/DNA complexes: PEGylation and phospholipid coating(2012)48 cited
- → MicroRNA Delivery with Bioreducible Polyethylenimine as a Non‐Viral Vector for Breast Cancer Gene Therapy(2019)39 cited
- → Bioreducible and acid-labile poly(amido amine)s for efficient gene delivery(2012)15 cited
- → Hydrophobic and hydrophilic modifications of polyethylenimine towards gene delivery applications(2021)14 cited